BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

CEL-SCI Corporation 

8229 Boone Boulevard
Suite 802
Vienna  Virginia  22182  U.S.A.
Phone: 703-506-9460 Fax: 703-506-9471


SEARCH JOBS








 Company News
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock And Six Month Warrants 4/14/2014 9:49:41 AM    More...
CEL-SCI (CVM) Prices $10 Million Public Offering Of Common Stock And Six Month Warrants 4/14/2014 7:52:12 AM    More...
Henry Ford Health System Of Detroit To Enroll And Treat Patients In CEL-SCI (CVM)’s Phase 3 Head And Neck Cancer Clinical Trial 4/8/2014 10:03:18 AM    More...
Arizona Cancer Research Alliance & 21st Century Oncology To Enroll Patients In CEL-SCI (CVM)’s Global Phase 3 Head and Neck Cancer Trial 4/2/2014 11:02:58 AM    More...
CEL-SCI (CVM) Reports March 2014 Is Record Month For Patient Enrollment In Phase 3 Head And Neck Cancer Trial 4/1/2014 11:30:37 AM    More...
CEL-SCI (CVM): Significant Potential, But A Long Way From Results 3/28/2014 9:43:28 AM    More...
CEL-SCI (CVM) CEO Geert Kersten To Be Interviewed Live Today On Clear Channel Business Talk Radio 3/26/2014 11:01:31 AM    More...
CEL-SCI (CVM) Reports 146 Patients Enrolled In Its Phase 3 Immunotherapy Head And Neck Cancer Trial 2/27/2014 9:55:57 AM    More...
CEL-SCI (CVM) Reports First Quarter 2014 Financial Results 2/11/2014 10:48:00 AM    More...
CEL-SCI (CVM) To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/7/2014 7:06:14 AM    More...
12345678910...

//-->